Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A training and education program for genome medical research coordinators in the genome cohort study of the Tohoku Medical Megabank Organization.

Sakurai-Yageta M, Kawame H, Kuriyama S, Hozawa A, Nakaya N, Nagami F, Minegishi N, Ogishima S, Takai-Igarashi T, Danjoh I, Obara T, Ishikuro M, Kobayashi T, Aizawa Y, Ishihara R, Yamamoto M, Suzuki Y.

BMC Med Educ. 2019 Aug 2;19(1):297. doi: 10.1186/s12909-019-1725-5.

2.

3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome.

Tadaka S, Katsuoka F, Ueki M, Kojima K, Makino S, Saito S, Otsuki A, Gocho C, Sakurai-Yageta M, Danjoh I, Motoike IN, Yamaguchi-Kabata Y, Shirota M, Koshiba S, Nagasaki M, Minegishi N, Hozawa A, Kuriyama S, Shimizu A, Yasuda J, Fuse N; Tohoku Medical Megabank Project Study Group, Tamiya G, Yamamoto M, Kinoshita K.

Hum Genome Var. 2019 Jun 18;6:28. doi: 10.1038/s41439-019-0059-5. eCollection 2019.

3.

Genome analyses for the Tohoku Medical Megabank Project towards establishment of personalized healthcare.

Yasuda J, Kinoshita K, Katsuoka F, Danjoh I, Sakurai-Yageta M, Motoike IN, Kuroki Y, Saito S, Kojima K, Shirota M, Saigusa D, Otsuki A, Kawashima J, Yamaguchi-Kabata Y, Tadaka S, Aoki Y, Mimori T, Kumada K, Inoue J, Makino S, Kuriki M, Fuse N, Koshiba S, Tanabe O, Nagasaki M, Tamiya G, Shimizu R, Takai-Igarashi T, Ogishima S, Hozawa A, Kuriyama S, Sugawara J, Tsuboi A, Kiyomoto H, Ishii T, Tomita H, Minegishi N, Suzuki Y, Suzuki K, Kawame H, Tanaka H, Taki Y, Yaegashi N, Kure S, Nagami F; Tohoku Medical Megabank Project Study Group, Kosaki K, Sutoh Y, Hachiya T, Shimizu A, Sasaki M, Yamamoto M.

J Biochem. 2019 Feb 1;165(2):139-158. doi: 10.1093/jb/mvy096.

PMID:
30452759
4.

Regional genetic differences among Japanese populations and performance of genotype imputation using whole-genome reference panel of the Tohoku Medical Megabank Project.

Yasuda J, Katsuoka F, Danjoh I, Kawai Y, Kojima K, Nagasaki M, Saito S, Yamaguchi-Kabata Y, Tadaka S, Motoike IN, Kumada K, Sakurai-Yageta M, Tanabe O, Fuse N, Tamiya G, Higasa K, Matsuda F, Yasuda N, Iwasaki M, Sasaki M, Shimizu A, Kinoshita K, Yamamoto M.

BMC Genomics. 2018 Jul 24;19(1):551. doi: 10.1186/s12864-018-4942-0.

5.

Erratum to: Induction of the Matrix Metalloproteinase 13 Gene in Bronchial Epithelial Cells by Interferon and Identification of its Novel Functional Polymorphism.

Mashimo Y, Sakurai-Yageta M, Watanabe M, Arima T, Morita Y, Inoue Y, Sato K, Nishimuta T, Suzuki S, Watanabe H, Hoshioka A, Tomiita M, Yamaide A, Kohno Y, Okamoto Y, Shimojo N, Hata A, Suzuki Y.

Inflammation. 2016 Jun;39(3):963. No abstract available.

PMID:
27000798
6.

Induction of the Matrix Metalloproteinase 13 Gene in Bronchial Epithelial Cells by Interferon and Identification of its Novel Functional Polymorphism.

Mashimo Y, Sakurai-Yageta M, Watanabe M, Arima T, Morita Y, Inoue Y, Sato K, Nishimuta T, Suzuki S, Watanabe H, Hoshioka A, Tomiita M, Yamaide A, Kohno Y, Okamoto Y, Shimojo N, Hata A, Suzuki Y.

Inflammation. 2016 Jun;39(3):949-62. doi: 10.1007/s10753-015-0291-1. Erratum in: Inflammation. 2016 Jun;39(3):963.

PMID:
26635116
7.

Dynamic regulation of a cell adhesion protein complex including CADM1 by combinatorial analysis of FRAP with exponential curve-fitting.

Sakurai-Yageta M, Maruyama T, Suzuki T, Ichikawa K, Murakami Y.

PLoS One. 2015 Mar 17;10(3):e0116637. doi: 10.1371/journal.pone.0116637. eCollection 2015.

8.

Trans-homophilic interaction of CADM1 activates PI3K by forming a complex with MAGuK-family proteins MPP3 and Dlg.

Murakami S, Sakurai-Yageta M, Maruyama T, Murakami Y.

PLoS One. 2014 Sep 30;9(9):e110062. doi: 10.1371/journal.pone.0110062. eCollection 2014.

9.

Genomic and transcriptional alterations of cholangiocarcinoma.

Ito T, Sakurai-Yageta M, Goto A, Pairojkul C, Yongvanit P, Murakami Y.

J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):380-7. doi: 10.1002/jhbp.67. Epub 2014 Feb 13. Review.

PMID:
24532422
10.

Trans-homophilic interaction of CADM1 activates PI3K by forming a complex with MAGuK-family proteins MPP3 and Dlg.

Murakami S, Sakurai-Yageta M, Maruyama T, Murakami Y.

PLoS One. 2014 Feb 4;9(2):e82894. doi: 10.1371/journal.pone.0082894. eCollection 2014.

11.

Expression of a splicing variant of the CADM1 specific to small cell lung cancer.

Kikuchi S, Iwai M, Sakurai-Yageta M, Tsuboi Y, Ito T, Maruyama T, Tsuda H, Kanai Y, Onizuka M, Sato Y, Murakami Y.

Cancer Sci. 2012 Jun;103(6):1051-7. doi: 10.1111/j.1349-7006.2012.02277.x. Epub 2012 May 15.

12.

Transcriptional regulation of the CADM1 gene by retinoic acid during the neural differentiation of murine embryonal carcinoma P19 cells.

Ito T, Williams-Nate Y, Iwai M, Tsuboi Y, Hagiyama M, Ito A, Sakurai-Yageta M, Murakami Y.

Genes Cells. 2011 Jul;16(7):791-802. doi: 10.1111/j.1365-2443.2011.01525.x. Epub 2011 Jun 15.

13.

Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma.

Nagata M, Sakurai-Yageta M, Yamada D, Goto A, Ito A, Fukuhara H, Kume H, Morikawa T, Fukayama M, Homma Y, Murakami Y.

Int J Cancer. 2012 Mar 15;130(6):1329-37. doi: 10.1002/ijc.26160. Epub 2011 Jul 21.

14.

Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.

Takahashi Y, Iwai M, Kawai T, Arakawa A, Ito T, Sakurai-Yageta M, Ito A, Goto A, Saito M, Kasumi F, Murakami Y.

Breast Cancer. 2012 Jul;19(3):242-52. doi: 10.1007/s12282-011-0272-7. Epub 2011 Apr 28.

PMID:
21526423
15.

Tumor suppressor CADM1 is involved in epithelial cell structure.

Sakurai-Yageta M, Masuda M, Tsuboi Y, Ito A, Murakami Y.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):977-82. doi: 10.1016/j.bbrc.2009.10.088. Epub 2009 Oct 23.

PMID:
19854157
16.

The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA.

Sakurai-Yageta M, Recchi C, Le Dez G, Sibarita JB, Daviet L, Camonis J, D'Souza-Schorey C, Chavrier P.

J Cell Biol. 2008 Jun 16;181(6):985-98. doi: 10.1083/jcb.200709076. Epub 2008 Jun 9.

17.

Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4.

Williams YN, Masuda M, Sakurai-Yageta M, Maruyama T, Shibuya M, Murakami Y.

Oncogene. 2006 Mar 9;25(10):1446-53.

PMID:
16261159
18.

Tumor suppressor in lung cancer (TSLC)1 suppresses epithelial cell scattering and tubulogenesis.

Masuda M, Kikuchi S, Maruyama T, Sakurai-Yageta M, Williams YN, Ghosh HP, Murakami Y.

J Biol Chem. 2005 Dec 23;280(51):42164-71. Epub 2005 Oct 13.

19.

Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma.

Yamada D, Kikuchi S, Williams YN, Sakurai-Yageta M, Masuda M, Maruyama T, Tomita K, Gutmann DH, Kakizoe T, Kitamura T, Kanai Y, Murakami Y.

Int J Cancer. 2006 Feb 15;118(4):916-23.

20.

Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.

Kikuchi S, Yamada D, Fukami T, Masuda M, Sakurai-Yageta M, Williams YN, Maruyama T, Asamura H, Matsuno Y, Onizuka M, Murakami Y.

Clin Cancer Res. 2005 Apr 15;11(8):2954-61.

21.

Detection of allelic imbalance in the gene expression of hMSH2 or RB1 in lymphocytes from pedigrees of hereditary, nonpolyposis, colorectal cancer and retinoblastoma by an RNA difference plot.

Murakami Y, Isogai K, Tomita H, Sakurai-Yageta M, Maruyama T, Hidaka A, Nose K, Sugano K, Kaneko A.

J Hum Genet. 2004;49(11):635-41. Epub 2004 Oct 8.

PMID:
15480874

Supplemental Content

Loading ...
Support Center